MustGrow Biologics Corp.
MustGrow Biologics Corp. (MGROF) Stock Overview
Explore MustGrow Biologics Corp.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
22.7M
P/E Ratio
-4.62
EPS (TTM)
$-0.09
ROE
-4.60%
MGROF Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of MustGrow Biologics Corp. (MGROF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 42.24, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.33.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -4.62 and a market capitalization of 22.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.